In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome.
Where this comes from
- Record sourced from PubMed, PMID 35226533.
- Also identified by DOI 10.7326/J22-0010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Goud R, Lufkin B, Duffy J, et al. <b>Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries.</b> JAMA Intern Med. 2021;181:1623-30. 34724025.
Medical subject headings
- Guillain-Barre Syndrome
- Herpes Zoster
- Herpes Zoster Vaccine
- Influenza Vaccines